Status:
UNKNOWN
TapTalkTest Project:Development of a Non-invasive Screening Test to Detect Risk of Alzheimer's Disease Pathology
Lead Sponsor:
University of Tasmania
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
50+ years
Brief Summary
This project aims to produce a solution for the rising incidence of dementia. This is particularly pertinent in Tasmania, Australia, with a rapidly ageing population and the oldest demographics of all...
Detailed Description
This project aims to produce a solution for the rising incidence of dementia. This is particularly pertinent in Tasmania, with a rapidly ageing population. The investigators' will develop TapTalk, a n...
Eligibility Criteria
Inclusion
- AIM 1 AND AIM 2 Eligibility criteria
- Adults \>50 years old who are participants in the ISLAND Project and who have provided a blood sample and have normal cognition and no persistent (\>3 months) cognitive symptoms will be eligible.
Exclusion
- Impaired cognition, defined by a validated cut-off score \>1.5 SD above the mean total errors adjusted for age and gender on the Paired Associates Learning sub-test of CANTAB.
- AIM 3 Eligibility criteria Inclusion Criteria: \>3 months of persistent cognitive symptoms (patient- or family-reported) and \>50 years old.
- Exclusion criteria: Acutely unwell, significant impairment of hand function, or known diagnosis of mild cognitive impairment (MCI) or dementia.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06114914
Start Date
August 1 2022
End Date
December 31 2025
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tasmania
Hobart, Tasmania, Australia, 7001